VC  Fountainhead Venture Group

http://www.fountainheadventure.com





     Office Locations:

Philadelphia, PA
Phone: 610-415-1240
Fax: 610-983-9376

 

Stages:

  • Early
  • Growth


 

Industries:

  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    Fountainhead Venture Group is a Philadelphia-based investment partnership that makes early- to mid-stage venture capital investments at the intersection of health care, life sciences, and information technology. We look for companies providing technology-based products and services or technology-enabled new business models to health care payers and providers or to the pharmaceutical and life sciences industries. Fountainhead was founded by Tom Olenzak, John Braca, and Frank Lexa, all experienced health care venture capitalists. Tom founded and ran the First Ventures Healthcare and Life Sciences Investment Fund, LLC, a corporate venture fund formed by First Consulting Group, Inc. (Nasdaq: FCGI) to invest in emerging health care and life sciences technology companies. John was most recently a General Partner of S.R. One, the venture capital arm of GlaxoSmithKline, and was a partner and founder of EuclidSR investments. Frank is a practicing physician and a professor with both the School of Medicine and the Wharton School at the University of Pennsylvania, and was a partner with Philadelphia Ventures.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Frank Lexa Managing Director
    John Braca Managing Director
    Tom Olenzak Managing Director

     

    Portfolio companies include:

     

    Recent News: